Flomax Study for Floppy Iris Syndrome
Diagnostic Imaging for Intraoperative Floppy Iris Syndrome
1 other identifier
observational
36
1 country
1
Brief Summary
Some men who have a history of use of Tamsulosin (Flomax) are at risk for a condition called Intraoperative Floppy Iris Syndrome that can develop during otherwise routine cataract surgery. It is not fully understood why this condition develops or who is at risk for developing it. In this study the investigators will take pictures of the iris and iris blood vessels before cataract surgery. The investigators hope that the results of this study will provide a better understanding of how Intraoperative Floppy Iris Syndrome develops and give us a non-surgical way of figuring out who might develop this problem during surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 2, 2010
CompletedFirst Posted
Study publicly available on registry
December 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedApril 28, 2015
April 1, 2015
3.5 years
December 2, 2010
April 24, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative Floppy Iris Syndrome
during cataract surgery
Study Arms (2)
Flomax
Male patients scheduled for cataract surgery with current or past use of Flomax
Control
Male adult patients scheduled for cataract surgery with no history of Flomax use
Eligibility Criteria
Adult male patients seen and scheduled for cataract surgery at the Kellogg eye Centers in Ann Arbor, Livonia and Brighton campuses.
You may qualify if:
- Male
- years or older
- Scheduled for Cataract Surgery
- Current or Past use of Tamsulosin (flomax)
- Blue colored iris
- For controls, no history of Flomax
You may not qualify if:
- Females
- Diabetes
- Glaucoma
- Use of medicated eye drops
- Trauma or prior surgery to the eye
- Black or brown iris
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kellogg Eye Center, 1000 Wall Street
Ann Arbor, Michigan, 48105, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Roni Shtein, MD
University of Michigan Kellogg Eye Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Ophthalmology and Visual Sciences
Study Record Dates
First Submitted
December 2, 2010
First Posted
December 3, 2010
Study Start
June 1, 2010
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
April 28, 2015
Record last verified: 2015-04